Recent Posts
- Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay
- Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors
- Chembio Diagnostics Announces Agreement for Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK Assay at Chembio Diagnostics Malaysia Facility
- Chembio Announces EUA Submission for DPP Respiratory Antigen Panel: Test Provides Simultaneous Detection of Flu A, Flu B, and SARS-CoV-2
- Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay
Recent Comments